Neuromeka Co., Ltd. (KOSDAQ:348340)
16,470
-740 (-4.30%)
Oct 30, 2026, 3:30 PM KST
Neuromeka Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 18,156 | 18,954 | 25,269 | 13,743 | 9,755 | 7,351 |
Revenue Growth | -13.12% | -24.99% | 83.87% | 40.89% | 32.69% | 80.81% |
Gross Profit Gross Profit Growth | 3,336 | 3,320 | 4,061 | 1,163 | 1,083 | 1,797 |
Operating Income Operating Income Growth | -16,257 | -14,857 | -19,439 | -14,825 | -7,809 | -3,009 |
Net Income Net Income Growth | -40,156 | -21,973 | -16,755 | -17,654 | -8,201 | -6,594 |
Earnings Per Share EPS Growth | -2264.87 | -1304.25 | -1059.33 | -1129.33 | -635.33 | -610.82 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
South Korea South Korea Growth | 17,698 | 17,940 | 24,598 | 13,634 | 9,271 | 7,271 |
USA USA Growth | -285.37 | 239.87 | 371.85 | 0.96 | 349.86 | 32.06 |
Other Other Growth | 33.95 | 65.18 | 98.19 | 29.89 | - | - |
China China Growth | - | 709.19 | 201.11 | 77.91 | 133.78 | 17.23 |
Total Total Growth | 18,156 | 18,954 | 25,269 | 13,743 | 9,755 | 7,351 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 13,404 | 18,228 | 20,035 | 40,955 | 28,790 | 15,891 |
Total Debt Total Debt Growth | 49,016 | 53,524 | 55,591 | 41,077 | 2,318 | 3,629 |
Net Cash (Debt) Net Cash Growth | -35,611 | -35,296 | -35,556 | -121.93 | 26,472 | 12,262 |
Net Cash Growth | - | - | - | - | 115.88% | 13304.69% |
Net Cash Per Share Net Cash Per Share Growth | -2008.57 | -2095.07 | -2247.82 | -7.80 | 2050.90 | 1135.86 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -18,562 | -11,358 | -21,930 | -12,434 | -7,999 | -1,056 |
Capital Expenditures CapEx Growth | -5,257 | -3,153 | -13,695 | -30,491 | -3,009 | -210.55 |
Free Cash Flow Free Cash Flow Growth | -23,819 | -14,511 | -35,625 | -42,925 | -11,008 | -1,267 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 18.38% | 17.52% | 16.07% | 8.46% | 11.10% | 24.44% |
Operating Margin | -89.54% | -78.38% | -76.93% | -107.88% | -80.06% | -40.93% |
Pretax Margin | -221.73% | -115.67% | -66.18% | -128.40% | -84.07% | -89.70% |
Profit Margin | -221.17% | -115.93% | -66.30% | -128.46% | -84.07% | -89.70% |
FCF Margin | -131.19% | -76.56% | -140.98% | -312.34% | -112.85% | -17.23% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 107.87 | 107.87 | 91.04 | - | - |
PS Ratio | 16.89 | 19.76 | 12.06 | 28.24 | 13.19 | - |